Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency - most related articles:

- 2 new pancreatic enzyme products Ultresa and Viokace to aid food digestion - 7.8
- Eurand's Zenpep pancreatic enzyme product approved by FDA - 7.7
- Early detection methods for pancreatic cancer urgently needed - 6
- Pancreatic cancer risk reduced by diabetes drug metformin - 5.6
- Obesity increases pancreatic cancer risk - 5.3
- Dietary fat from red meat and dairy linked to pancreatic cancer - 5
- New drug reverses resistance to chemotherapy in pancreatic cancer patients - 4.5
- Nigella sativa herbal extract may cure pancreatic cancer - 4.5
- CCSVI role in multiple sclerosis seems to be controversial - 4.4
- Pancreatic cancers progress to lethal stage slowly - 4.3

Exocrine Pancreatic Insufficiency articles

Eurand's Zenpep pancreatic enzyme product approved by FDA
U.S. Food and Drug Administration (FDA) has approved Eurand's New Drug Application (NDA) for ZENPEP(TM) (pancrelipase) Delayed-Release Capsules for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.

1 Exocrine Pancreatic Insufficiency articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
12.67